0001651308-24-000018.txt : 20240304 0001651308-24-000018.hdr.sgml : 20240304 20240304172447 ACCESSION NUMBER: 0001651308-24-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRANDICOURT OLIVIER CENTRAL INDEX KEY: 0001508518 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37686 FILM NUMBER: 24716048 MAIL ADDRESS: STREET 1: PFIZER INC. ATTN. CORP. SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BeiGene, Ltd. CENTRAL INDEX KEY: 0001651308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981209416 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN) STREET 2: 94 SOLARIS AVENUE, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 BUSINESS PHONE: 13459494123 MAIL ADDRESS: STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN) STREET 2: 94 SOLARIS AVENUE, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 4 1 wk-form4_1709591065.xml FORM 4 X0508 4 2024-02-29 0 0001651308 BeiGene, Ltd. BGNE 0001508518 BRANDICOURT OLIVIER C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 CAYMAN ISLANDS 1 0 0 0 0 Share Option (Right to Buy) 12.74 2024-02-29 4 A 0 27794 0 A 2034-02-28 Ordinary Shares 27794 27794 D The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended. /s/ Qing Nian, as Attorney-in-Fact 2024-03-04